Zobrazeno 1 - 10
of 76
pro vyhledávání: '"Partridge, Ann"'
Autor:
Irwin ML; Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, Connecticut.; Department of Internal Medicine, Section of Medical Oncology, Yale School of Medicine, New Haven, Connecticut., Cartmel B; Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, Connecticut.; Department of Internal Medicine, Section of Medical Oncology, Yale School of Medicine, New Haven, Connecticut., Harrigan M; Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, Connecticut., Li F; Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, Connecticut., Sanft T; Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, Connecticut.; Department of Internal Medicine, Section of Medical Oncology, Yale School of Medicine, New Haven, Connecticut., Shockro L; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., O'Connor K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Campbell N; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Tolaney SM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Mayer EL; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Yung R; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Freedman RA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Partridge AH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Ligibel JA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
Publikováno v:
Cancer [Cancer] 2017 Apr 01; Vol. 123 (7), pp. 1249-1258. Date of Electronic Publication: 2016 Nov 28.
Autor:
Zhou ES; Dana-Farber Cancer Institute, Boston, Massachusetts, USA. eric_zhou@dfci.harvard.edu., Partridge AH; Dana-Farber Cancer Institute, Boston, Massachusetts, USA. ann_partridge@dfci.harvard.edu., Blackmon JE; Dana-Farber Cancer Institute, Boston, Massachusetts, USA. jaime_blackmon@dfci.harvard.edu., Morgan E; Dana-Farber Cancer Institute, Boston, Massachusetts, USA. evan_morgan@dfci.harvard.edu., Recklitis CJ; Dana-Farber Cancer Institute, Boston, Massachusetts, USA. christopher_recklitis@dfci.harvard.edu.
Publikováno v:
Rural and remote health [Rural Remote Health] 2016 Apr-Jun; Vol. 16 (2), pp. 3863. Date of Electronic Publication: 2016 Jun 15.
Autor:
Ruddy KJ; Mayo Clinic, Rochester, MN ruddy.kathryn@mayo.edu., Risendal BC; University of Colorado Cancer Center, Aurora, CO., Garber JE; Dana-Farber Cancer Institute, Boston, MA., Partridge AH; Dana-Farber Cancer Institute, Boston, MA.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2016 Feb 20; Vol. 34 (6), pp. 539-41. Date of Electronic Publication: 2015 Dec 28.
Autor:
Palmer SC; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA; LIVESTRONG, Austin, TX; Fred Hutchinson Cancer Research Center, Seattle, WA; University of California, Los Angeles, Jonsson Comprehensive Cancer Center, Los Angeles, CA; Memorial Sloan Kettering Cancer Center, New York, NY; Dana-Farber Cancer Institute, Boston, MA; University of Colorado Cancer Center, Denver, CO; and University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC Stpalmer@mail.med.upenn.edu., Stricker CT; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA; LIVESTRONG, Austin, TX; Fred Hutchinson Cancer Research Center, Seattle, WA; University of California, Los Angeles, Jonsson Comprehensive Cancer Center, Los Angeles, CA; Memorial Sloan Kettering Cancer Center, New York, NY; Dana-Farber Cancer Institute, Boston, MA; University of Colorado Cancer Center, Denver, CO; and University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC., Panzer SL; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA; LIVESTRONG, Austin, TX; Fred Hutchinson Cancer Research Center, Seattle, WA; University of California, Los Angeles, Jonsson Comprehensive Cancer Center, Los Angeles, CA; Memorial Sloan Kettering Cancer Center, New York, NY; Dana-Farber Cancer Institute, Boston, MA; University of Colorado Cancer Center, Denver, CO; and University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC., Arvey SA; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA; LIVESTRONG, Austin, TX; Fred Hutchinson Cancer Research Center, Seattle, WA; University of California, Los Angeles, Jonsson Comprehensive Cancer Center, Los Angeles, CA; Memorial Sloan Kettering Cancer Center, New York, NY; Dana-Farber Cancer Institute, Boston, MA; University of Colorado Cancer Center, Denver, CO; and University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC., Baker KS; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA; LIVESTRONG, Austin, TX; Fred Hutchinson Cancer Research Center, Seattle, WA; University of California, Los Angeles, Jonsson Comprehensive Cancer Center, Los Angeles, CA; Memorial Sloan Kettering Cancer Center, New York, NY; Dana-Farber Cancer Institute, Boston, MA; University of Colorado Cancer Center, Denver, CO; and University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC., Casillas J; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA; LIVESTRONG, Austin, TX; Fred Hutchinson Cancer Research Center, Seattle, WA; University of California, Los Angeles, Jonsson Comprehensive Cancer Center, Los Angeles, CA; Memorial Sloan Kettering Cancer Center, New York, NY; Dana-Farber Cancer Institute, Boston, MA; University of Colorado Cancer Center, Denver, CO; and University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC., Ganz PA; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA; LIVESTRONG, Austin, TX; Fred Hutchinson Cancer Research Center, Seattle, WA; University of California, Los Angeles, Jonsson Comprehensive Cancer Center, Los Angeles, CA; Memorial Sloan Kettering Cancer Center, New York, NY; Dana-Farber Cancer Institute, Boston, MA; University of Colorado Cancer Center, Denver, CO; and University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC., McCabe MS; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA; LIVESTRONG, Austin, TX; Fred Hutchinson Cancer Research Center, Seattle, WA; University of California, Los Angeles, Jonsson Comprehensive Cancer Center, Los Angeles, CA; Memorial Sloan Kettering Cancer Center, New York, NY; Dana-Farber Cancer Institute, Boston, MA; University of Colorado Cancer Center, Denver, CO; and University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC., Nekhlyudov L; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA; LIVESTRONG, Austin, TX; Fred Hutchinson Cancer Research Center, Seattle, WA; University of California, Los Angeles, Jonsson Comprehensive Cancer Center, Los Angeles, CA; Memorial Sloan Kettering Cancer Center, New York, NY; Dana-Farber Cancer Institute, Boston, MA; University of Colorado Cancer Center, Denver, CO; and University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC., Overholser L; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA; LIVESTRONG, Austin, TX; Fred Hutchinson Cancer Research Center, Seattle, WA; University of California, Los Angeles, Jonsson Comprehensive Cancer Center, Los Angeles, CA; Memorial Sloan Kettering Cancer Center, New York, NY; Dana-Farber Cancer Institute, Boston, MA; University of Colorado Cancer Center, Denver, CO; and University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC., Partridge AH; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA; LIVESTRONG, Austin, TX; Fred Hutchinson Cancer Research Center, Seattle, WA; University of California, Los Angeles, Jonsson Comprehensive Cancer Center, Los Angeles, CA; Memorial Sloan Kettering Cancer Center, New York, NY; Dana-Farber Cancer Institute, Boston, MA; University of Colorado Cancer Center, Denver, CO; and University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC., Risendal B; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA; LIVESTRONG, Austin, TX; Fred Hutchinson Cancer Research Center, Seattle, WA; University of California, Los Angeles, Jonsson Comprehensive Cancer Center, Los Angeles, CA; Memorial Sloan Kettering Cancer Center, New York, NY; Dana-Farber Cancer Institute, Boston, MA; University of Colorado Cancer Center, Denver, CO; and University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC., Rosenstein DL; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA; LIVESTRONG, Austin, TX; Fred Hutchinson Cancer Research Center, Seattle, WA; University of California, Los Angeles, Jonsson Comprehensive Cancer Center, Los Angeles, CA; Memorial Sloan Kettering Cancer Center, New York, NY; Dana-Farber Cancer Institute, Boston, MA; University of Colorado Cancer Center, Denver, CO; and University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC., Syrjala KL; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA; LIVESTRONG, Austin, TX; Fred Hutchinson Cancer Research Center, Seattle, WA; University of California, Los Angeles, Jonsson Comprehensive Cancer Center, Los Angeles, CA; Memorial Sloan Kettering Cancer Center, New York, NY; Dana-Farber Cancer Institute, Boston, MA; University of Colorado Cancer Center, Denver, CO; and University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC., Jacobs LA; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA; LIVESTRONG, Austin, TX; Fred Hutchinson Cancer Research Center, Seattle, WA; University of California, Los Angeles, Jonsson Comprehensive Cancer Center, Los Angeles, CA; Memorial Sloan Kettering Cancer Center, New York, NY; Dana-Farber Cancer Institute, Boston, MA; University of Colorado Cancer Center, Denver, CO; and University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC.
Publikováno v:
Journal of oncology practice [J Oncol Pract] 2015 Mar; Vol. 11 (2), pp. e222-9.
Autor:
Korde LA; 1 Division of Medical Oncology, University of Washington , Seattle, Washington., Partridge AH; 2 Dana-Farber Cancer Institute , Boston, Massachusetts., Esser M; 3 Young Survival Coalition , New York, New York., Lewis S; 3 Young Survival Coalition , New York, New York., Simha J; 3 Young Survival Coalition , New York, New York., Johnson RH; 4 Mary Bridge Children's Hospital , Multicare Health System, Tacoma, Washington.
Publikováno v:
Journal of adolescent and young adult oncology [J Adolesc Young Adult Oncol] 2015 Mar; Vol. 4 (1), pp. 34-43.
Autor:
Partridge AH; From the Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA; Moffitt Cancer Center, Tampa, FL; Department of Psychology, The Ohio State University, Columbus, OH., Jacobsen PB; From the Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA; Moffitt Cancer Center, Tampa, FL; Department of Psychology, The Ohio State University, Columbus, OH., Andersen BL; From the Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA; Moffitt Cancer Center, Tampa, FL; Department of Psychology, The Ohio State University, Columbus, OH.
Publikováno v:
American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting [Am Soc Clin Oncol Educ Book] 2015, pp. 188-94.
Autor:
Boyajian RN; Dana Farber Cancer Institute; Simmons College; Harvard Medical School; Harvard Vanguard Medical Associates, Boston, MA; and University of North Carolina, Chapel Hill, NC rboyajian@partners.org., Grose A; Dana Farber Cancer Institute; Simmons College; Harvard Medical School; Harvard Vanguard Medical Associates, Boston, MA; and University of North Carolina, Chapel Hill, NC., Grenon N; Dana Farber Cancer Institute; Simmons College; Harvard Medical School; Harvard Vanguard Medical Associates, Boston, MA; and University of North Carolina, Chapel Hill, NC., Roper K; Dana Farber Cancer Institute; Simmons College; Harvard Medical School; Harvard Vanguard Medical Associates, Boston, MA; and University of North Carolina, Chapel Hill, NC., Sommer K; Dana Farber Cancer Institute; Simmons College; Harvard Medical School; Harvard Vanguard Medical Associates, Boston, MA; and University of North Carolina, Chapel Hill, NC., Walsh M; Dana Farber Cancer Institute; Simmons College; Harvard Medical School; Harvard Vanguard Medical Associates, Boston, MA; and University of North Carolina, Chapel Hill, NC., Snavely A; Dana Farber Cancer Institute; Simmons College; Harvard Medical School; Harvard Vanguard Medical Associates, Boston, MA; and University of North Carolina, Chapel Hill, NC., Neary S; Dana Farber Cancer Institute; Simmons College; Harvard Medical School; Harvard Vanguard Medical Associates, Boston, MA; and University of North Carolina, Chapel Hill, NC., Partridge A; Dana Farber Cancer Institute; Simmons College; Harvard Medical School; Harvard Vanguard Medical Associates, Boston, MA; and University of North Carolina, Chapel Hill, NC., Nekhlyudov L; Dana Farber Cancer Institute; Simmons College; Harvard Medical School; Harvard Vanguard Medical Associates, Boston, MA; and University of North Carolina, Chapel Hill, NC.
Publikováno v:
Journal of oncology practice [J Oncol Pract] 2014 Sep; Vol. 10 (5), pp. e293-8. Date of Electronic Publication: 2014 Jun 24.
Autor:
McCabe MS; Survivorship Program, Memorial Sloan Kettering Cancer Center, New York, NY., Partridge AH; Adult Survivorship Program, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, MA., Grunfeld E; Ontario Institute for Cancer Research and Department of Family and Community Medicine, University of Toronto, Ontario, Canada., Hudson MM; Cancer Survivorship Division, St. Jude Children's Research Hospital, Memphis, TN. Electronic address: melissa.hudson@stjude.org.
Publikováno v:
Seminars in oncology [Semin Oncol] 2013 Dec; Vol. 40 (6), pp. 804-12.
Autor:
Ganz PA; University of California, Los Angeles, CA, USA., Yip CH, Gralow JR, Distelhorst SR, Albain KS, Andersen BL, Bevilacqua JL, de Azambuja E, El Saghir NS, Kaur R, McTiernan A, Partridge AH, Rowland JH, Singh-Carlson S, Vargo MM, Thompson B, Anderson BO
Publikováno v:
Breast (Edinburgh, Scotland) [Breast] 2013 Oct; Vol. 22 (5), pp. 606-15. Date of Electronic Publication: 2013 Sep 03.
Autor:
Partridge AH; Program for Young Women with Breast Cancer, Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA. ahpartridge@partners.org
Publikováno v:
The oncologist [Oncologist] 2013; Vol. 18 (8), pp. e19-20.